Voss, M. H., Chen, D., Marker, M., Hakimi, A. A., Lee, C., Hsieh, J. J., . . . Motzer, R. J. (2016). Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma. Br J Cancer.

Voss, Martin H., David Chen, Mahtab Marker, A Ari Hakimi, Chung-Han Lee, James J. Hsieh, Jennifer J. Knox, Maurizio Voi, and Robert J. Motzer. "Circulating Biomarkers and Outcome From a Randomised Phase II Trial of Sunitinib Vs Everolimus for Patients With Metastatic Renal Cell Carcinoma." Br J Cancer 2016.

Voss, Martin H., et al. "Circulating Biomarkers and Outcome From a Randomised Phase II Trial of Sunitinib Vs Everolimus for Patients With Metastatic Renal Cell Carcinoma." Br J Cancer 2016.